Switching to DOR/3TC/TDF Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial

Authors
Category Primary study
JournalJAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Year 2021
This article has no abstract
Epistemonikos ID: c24efd22b87d5f8635e01e07da8fb8f55d227f10
First added on: Nov 22, 2025